1 domain / 2 areas / 1 specialization
Emory University
Data updated
The Center for Psychedelics and Spirituality at Emory University combines expertise in psychiatry with spiritual health to better understand the therapeutic promise of psychedelics as medicine. Launched at the end of 2022, the group works towards making psychedelic-assisted therapies more effective within a wide cultural and spiritual context.
Academic Research
0 papersPublished Papers
0
Trial Involvement
6
Distinct Focus Topics
0
Latest Publication
Unknown
Government funding received
1 grantDoD — MDMA-assisted therapy + massed prolonged exposure for active-duty PTSD
2025
Part of the DoD's first-ever financial commitment to modern psychedelics clinical trials ($9.8M across two $4.9M awards). Two-armed, double-blind RCT of 100 active-duty / National Guard / Reserve personnel comparing MDMA-assisted therapy + Massed Prolonged Exposure. Led by Barbara Rothbaum (Emory) and Alan Peterson (STRONG STAR Consortium / UT Health San Antonio).
SourceQuick Facts
- Type
- academic
- HQ
- United States
- Website
- Visit
Research Landscape
What the 6 registered trials Emory University sponsors or participates in look like when you line them up. Counts come from Blossom’s trial records as of July 2026.
What's live right now, and what stopped?
SourcedRegistry status of all 6 Emory University trials Blossom tracks. Orange marks trials recruiting or opening.
Don't read stopped trials as failures: trials end early for funding, recruitment, and strategy reasons too. Status is as last synced from the registry; some 'recruiting' trials may already have finished.